Metraipolis › archive › dc_dbac4d1815c6

Efficacy and Safety of Faricimab in Diabetic Macular Edema: Real-World Outcomes in Treatment-Naïve and Previously Treated Eyes — Europe PMC PMID:40943933

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40943933
DOI
10.3390/jcm14176173
License (as archived)
solo-consultazione
Archived
2026-11-10T04:56:45.222Z
SHA-256 of the archived text
c62c759d692f7081810f867874a0981aea48de74512a3b9c46783b63bd37e70e
Stable URL of this page
https://metraipolis.com/documento/dc_dbac4d1815c6

How to cite

Efficacy and Safety of Faricimab in Diabetic Macular Edema: Real-World Outcomes in Treatment-Naïve and Previously Treated Eyes — Europe PMC PMID:40943933 — Europe PMC (en), https://europepmc.org/article/MED/40943933 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbac4d1815c6 (Metraipolis archive dc_dbac4d1815c6, sha256 c62c759d692f7081810f867874a0981aea48de74512a3b9c46783b63bd37e70e)
BibTeX
@misc{dcdbac4d1815c6,
  title = {Efficacy and Safety of Faricimab in Diabetic Macular Edema: Real-World Outcomes in Treatment-Naïve and Previously Treated Eyes — Europe PMC PMID:40943933},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40943933},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbac4d1815c6; sha256 c62c759d692f7081810f867874a0981aea48de74512a3b9c46783b63bd37e70e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40943933. Agents can read the archived copy with the MCP tool read_document.